Fu-an Wang
Yangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Transarterial Chemoembolization Plus Camrelizumab and Rivoceranib versus Camrelizumab and Rivoceranib Alone for BCLC Stage C Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: September 03, 2024
Transarterial Chemoembolization Plus Tyrosinkinase Inhibitors and PD-1 Inhibitors for Spontaneously Ruptured Hepatocellular Carcinoma.
Journal: Cardiovascular and interventional radiology
Published: August 10, 2023
Radiofrequency ablation is an inferior option to liver resection for solitary hepatocellular carcinoma ≤ 5 cm without cirrhosis: A population-based study with stratification by tumor size.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: December 01, 2021
Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: November 01, 2016
Radiofrequency Ablation in Treating Colorectal Cancer Patients with Liver Metastases.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: January 09, 2016
Efficacy of Transarterial Chemoembolization Combined with Radiofrequency Ablation in Treatment of Hepatocellular Carcinoma.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: September 01, 2015
Radiofrequency Ablation for Liver Metastases after Transarterial Chemoembolization: A Systemic Analysis.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: July 12, 2015
Safety and efficacy of sequential transcatheter arterial chemoembolization and portal vein embolization prior to major hepatectomy for patients with HCC.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: February 27, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026